Respiratory Diseases

>

Latest News

Single Afternoon Dose of ICS Linked to Better Lung Function and Reduced Inflammation in Asthma
Single Afternoon Dose of ICS Linked to Better Lung Function and Reduced Inflammation in Asthma

May 8th 2025

The chronotherapeutic approach aligns treatment with peak glucocorticoid sensitivity, so may mitigate onset of the inflammatory cascade that triggers nocturnal exacerbations.

Telehealth in Pediatric Primary Care Linked to Lower Antibiotic Prescribing for Respiratory Infections
Telehealth in Pediatric Primary Care Linked to Lower Antibiotic Prescribing for Respiratory Infections

April 29th 2025

 Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates / image credit ©Kateryna_Kon/stock.adobe.com
Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates

April 2nd 2025

Omlyclo Gains FDA Approval as Interchangeable Omalizumab Biosimilar: Daily Dose / image credit: ©New Africa/AdobeStock
Omlyclo Gains FDA Approval as Interchangeable Omalizumab Biosimilar: Daily Dose

March 24th 2025

Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose / image credit: ©New Africa/AdobeStock
Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose

March 20th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.